To examine which biomarker-based measures correlated most strongly with clinical assessment of RA disease activity, the associations with DAS28* for CRP and each MBDA score were assessed in the same clinical trial/registry cohort (n = 1411) that was used for BMI adjustment. This evidence concerns the gene CRP and rheumatoid arthritis.